Logo image
Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations
Journal article   Peer reviewed

Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations

Andrea Napolitano, Heikki Joensuu, Sara Rothschild, Denisse Evans, Michael C. Heinrich, Thomas L. Sutton, Skye C. Mayo, Kjetil Boye, Johanna Falkenhorst, Axel Le Cesne, …
JAMA oncology
2026-02-26
PMID: 41746633

Abstract

Brief Report Comments Online First
This cohort study evaluates the association between adjuvant imatinib and recurrence-free survival and overall survival in patients with resected high-risk gastrointestinal stromal tumors (GISTs) with KIT exon 9 mutations.

Metrics

1 Record Views

Details

Logo image